InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-07 · accession 0001179110-22-000399 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-01-11 2022-01-07 PTCT Boulding Mark Elliott EVP, CLO S - Sale $38.53 -885 47.5K -2% -$34.1K
D 2022-01-11 2022-01-07 PTCT Boulding Mark Elliott EVP, CLO A - Grant $0.00 +14.4K 61.9K +30% $0
D 2022-01-11 2022-01-07 PTCT Boulding Mark Elliott EVP, CLO A - Grant $0.00 +54.0K 54.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-01-07 S D 885 $38.53 47,489 D — — (F1) Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs.
2 Common Common Stock 2022-01-07 A A 14,400 $0.00 61,889 D — — (F2) Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
3 Derivative Stock Option (Right to Buy) 2022-01-07 A A 54,000 $0.00 54,000 D $38.10 · — to 2032-01-06 54,000 Common Stock (F3) This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.